{{Short description|Chemical compound}} {{Infobox drug | drug_name = HIE-124 | image = HIE-124_structure.svg | image_class = skin-invert-image | width = | caption =

<!-- Clinical data --> | pronounce = | tradename = | Drugs.com = | MedlinePlus = | licence_CA = | licence_EU = | DailyMedID = | licence_US = | pregnancy_AU = | pregnancy_category = | dependency_liability = | addiction_liability = | routes_of_administration = | class = | ATC_prefix = | ATC_suffix =

<!-- Legal status --> | legal_status =

<!-- Pharmacokinetic data --> | bioavailability = | protein_bound = | metabolism = | metabolites = | onset = | elimination_half-life = | duration_of_action = | excretion =

<!-- Identifiers --> | CAS_number = 805326-00-5 | CAS_supplemental = | PubChem = 11447815 | IUPHAR_ligand = | DrugBank = | ChemSpiderID = 9622668 | UNII = JS6A6EQZ44 | KEGG = | ChEBI = | ChEMBL = 450014 | NIAID_ChemDB = | PDB_ligand = | synonyms =

<!-- Chemical data --> | IUPAC_name = Ethyl 8-oxo-6,7-dihydro-5H-[1,3]thiazolo[3,2-a][1,3]diazepine-3-carboxylate | C=10 | H=12 | N=2 | O=3 | S=1 | SMILES = O=C(C1=CSC(N1CCC2)=NC2=O)OCC | StdInChI = 1S/C10H12N2O3S/c1-2-15-9(14)7-6-16-10-11-8(13)4-3-5-12(7)10/h6H,2-5H2,1H3 | StdInChIKey = UXGPDPNGDCOQBY-UHFFFAOYSA-N }}

'''HIE-124''' is an investigational nonbenzodiazepine drug being researched for its short acting hypnotic effects.<ref>{{cite journal | vauthors = Kadi A, El-Kashef H, Abdel-Aziz A, Hassan G, Tettey J, Grant M, Lehmann J, El-Subbagh H | title = Synthesis, ultra-short acting hypnotic activity, and metabolic profile of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a] [1,3]diazepin-3-carboxylate (HIE-124) | journal = Archiv der Pharmazie | volume = 341 | issue = 2 | pages = 81–89 | date = February 2008 | pmid = 18214840 | doi = 10.1002/ardp.200700132 | s2cid = 12263886 }}</ref>

== References == {{Reflist}}

{{sedative-stub}}

Category:Ethyl esters Category:Diazepines Category:Thiazoles Category:Nonbenzodiazepines